A biotechnology start-up in Pakistan, led by experts of a US-based company Byonyks Medical Devices, has developed a device, which will make dialysis process bloodless and affordable for kidney patients.
Considered to be Pakistan’s first bloodless risk-free dialysis machine, the device has been developed by the company in collaboration with Pakistan’s Ignite, which funds innovative start-ups, and angel investors.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The device, called Robo-Kidney, is designed to enable kidney patients to undergo blood dialysis at home without extracting blood from the body. It also eliminates the chance of contraction of disease such as HIV or hepatitis C infections, a risk usually associated with traditional dialysis practices.
It uses an automated peritoneal dialysis (APD) method of dialysis. The method involves a special machine to removes toxins and excess fluid from the body by instilling fluid in the stomach and subsequently draining it.
Byonyks founder and CEO Farrukh Usman said: “Robo-Kidney is an affordable and bloodless machine that will allow kidney patients to receive dialysis treatment from the comfort of their homes.”
According to reports, the device is currently being evaluated and trial data is being collected for feedback and patient health progress.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe government plans to manufacture the device on a commercial basis after receiving regulatory approvals with the aim of making dialysis affordable and convenient for kidney patients in the country.
Over 20 million people suffer from kidney disease in Pakistan. Kidney transplants and dialysis are the two options available to people with chronic kidney disease (CKD).
Hemodialysis, which is performed at a dialysis centre, is an expensive and time-consuming process, which the patients are required to undergo multiple times a month.
